Home > Insider Trading > Filing (0001209191-20-009837)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1080709	Arena Pharmaceuticals Inc	ARNA	Pharmaceutical Preparations (2834)	232908305

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1170362	W Steven Spector	C/O Arena Pharmaceuticals, Inc. 6154 Nancy Ridge Drive San Diego CA 92121	Evp, General Counsel & Sec	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-02-13	2,472	$32.50	15,339	No	4	M	Direct
Common Stock	Acquisiton	2020-02-13	4,964	$37.20	20,303	No	4	M	Direct
Common Stock	Disposition	2020-02-13	10,836	$55.00	9,467	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2020-02-13	2,472	$0.00	2,472	$32.50
Common Stock	Employee Stock Option (right to buy)	Disposition	2020-02-13	4,964	$0.00	4,964	$37.20

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,254		2020-03-17	No	4	M	Direct
2,536		2021-12-15	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person.
The options vested in four equal annual installments (except as otherwise necessary to avoid vesting of a fractional share) beginning on March 17, 2011, and ending on March 17, 2014, and became exercisable once vested.
The options vested in four equal annual installments (except as otherwise necessary to avoid vesting of a fractional share) beginning on December 15, 2015, and ending on December 15, 2018, and became exercisable once vested.